Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Irwin Naturals
(OTCQB:IWINF)
Intraday
$0.1482
0
[0.00%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$0.1482
0
[0.00%]
Last update: 10:42AM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Irwin Naturals Stock (OTC:IWINF)
Irwin Naturals Stock (OTC: IWINF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 05, 2023
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Lara Goldstein
-
Dec 5, 2023, 10:12AM
Tuesday, November 28, 2023
Irwin Naturals' Bold Leap: Cannabis, Psychedelics Drive Q3 Buzz Despite Falling Revenue & Surging Losses
Nina Zdinjak
-
Nov 28, 2023, 8:50AM
Tuesday, September 05, 2023
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Lara Goldstein
-
Sep 5, 2023, 10:07AM
Monday, August 28, 2023
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
Jelena Martinovic
-
Aug 28, 2023, 9:26AM
Friday, August 25, 2023
Cannabis Stock Gainers And Losers From August 25, 2023
Benzinga Insights
-
Aug 25, 2023, 5:30PM
Thursday, August 17, 2023
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
Benzinga Insights
-
Aug 17, 2023, 5:30PM
Tuesday, August 15, 2023
Marijuana Stock Movers For August 15, 2023
Benzinga Insights
-
Aug 15, 2023, 5:30PM
Thursday, August 10, 2023
Cannabis Stock Movers For August 10, 2023
Benzinga Insights
-
Aug 10, 2023, 5:30PM
Friday, July 28, 2023
Irwin Naturals Launches Trio Of Cannabis Tinctures In California
Vuk Zdinjak
-
Jul 28, 2023, 10:16AM
Thursday, July 27, 2023
Cannabis Stock Movers For July 27, 2023
Benzinga Insights
-
Jul 27, 2023, 5:30PM
Thursday, June 01, 2023
Irwin Naturals Q1 FY23 Revenue Stagnates YoY, What About Adjusted EBITDA?
Vuk Zdinjak
-
Jun 1, 2023, 8:02AM
Wednesday, May 31, 2023
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
Lara Goldstein
-
May 31, 2023, 11:59AM
Friday, May 26, 2023
Irwin Naturals FY22 Revenue Declines 10.8%, What About Adjusted EBITDA?
Vuk Zdinjak
-
May 26, 2023, 8:15AM
Monday, May 08, 2023
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
Lara Goldstein
-
May 8, 2023, 4:23PM
Friday, May 05, 2023
Cannabis Scandal And Resignation Of Oregon Official, USCC's New Leadership & More Executive Moves
Jelena Martinovic
-
May 5, 2023, 8:45AM
Wednesday, May 03, 2023
Psychedelics Company Confirms Shares Spinout, Another Fails To File Financials & Gets CTO Issue
Lara Goldstein
-
May 3, 2023, 7:49AM
Monday, May 01, 2023
Cantor Fitzgerald Discontinues Research Coverage Of The Cannabis Sector
Vuk Zdinjak
-
May 1, 2023, 11:09AM
Monday, March 27, 2023
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
Lara Goldstein
-
Mar 27, 2023, 6:39PM
Friday, March 24, 2023
Irwin Naturals Cannabis Products Launch Nationwide In Canada
Vuk Zdinjak
-
Mar 24, 2023, 8:21AM
Wednesday, March 22, 2023
Irwin Naturals Acquires Ketamine Media
Vuk Zdinjak
-
Mar 22, 2023, 8:29AM
Monday, March 20, 2023
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Lara Goldstein
-
Mar 20, 2023, 5:11PM
Thursday, March 16, 2023
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
Lara Goldstein
-
Mar 16, 2023, 4:03PM
Wednesday, March 15, 2023
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Lara Goldstein
-
Mar 15, 2023, 1:39PM
Monday, March 06, 2023
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
Lara Goldstein
-
Mar 6, 2023, 12:41PM
Thursday, March 02, 2023
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
Lara Goldstein
-
Mar 2, 2023, 2:26PM
Monday, February 27, 2023
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Lara Goldstein
-
Feb 27, 2023, 7:28PM
Tuesday, February 21, 2023
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Lara Goldstein
-
Feb 21, 2023, 5:19PM
Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA
Vuk Zdinjak
-
Feb 21, 2023, 8:57AM
Monday, February 06, 2023
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Lara Goldstein
-
Feb 6, 2023, 2:54PM
Friday, February 03, 2023
'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar
Lara Goldstein
-
Feb 3, 2023, 9:22AM
Thursday, February 02, 2023
Irwin Naturals Secures $40M To Accelerate Expansion Of Its Psychedelic Mental Health Clinics
Vuk Zdinjak
-
Feb 2, 2023, 9:03AM
Friday, January 27, 2023
Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics
Vuk Zdinjak
-
Jan 27, 2023, 8:47AM
Thursday, January 26, 2023
Irwin Naturals TCH Products To Hit The Shelves Of ~2700 Dispensaries In Oklahoma Via Gold Rush
Vuk Zdinjak
-
Jan 26, 2023, 9:14AM
Tuesday, January 24, 2023
Irwin Naturals, Numinus, Field Trip: Sector Analyst Compares Footprints, Cash, Organic Growth
Nicolás Jose Rodriguez
-
Jan 24, 2023, 12:06PM
Monday, January 23, 2023
Cantor Fitzgerald Maintains Overweight on Irwin Naturals, Lowers Price Target to $6
Benzinga Newsdesk
-
Jan 23, 2023, 5:56AM
Tuesday, January 10, 2023
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
Lara Goldstein
-
Jan 10, 2023, 3:53PM
Wednesday, December 21, 2022
Irwin Naturals To Enter Oregon Cannabis Market Via Hyphae Wellness
Vuk Zdinjak
-
Dec 21, 2022, 11:02AM
Tuesday, December 13, 2022
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More
Lara Goldstein
-
Dec 13, 2022, 3:21PM
Friday, December 09, 2022
Mental Health Clinic Poised To Become Leader In A Projected $50B Industry, Analyst Says
Jelena Martinovic
-
Dec 9, 2022, 11:06AM
Irwin Naturals Completes The Acquisition Of Three Mental Health Clinics
Vuk Zdinjak
-
Dec 9, 2022, 9:20AM
Cantor Fitzgerald Maintains Overweight on Irwin Naturals, Lowers Price Target to $6.2
Benzinga Newsdesk
-
Dec 9, 2022, 4:39AM
Tuesday, December 06, 2022
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Lara Goldstein
-
Dec 6, 2022, 2:20PM
Irwin Naturals Q3 Revenue Declines 7% YoY, What About Adjusted EBITDA?
Vuk Zdinjak
-
Dec 6, 2022, 8:03AM
Wednesday, November 30, 2022
Irwin Naturals To Acquire Serenity Health
Vuk Zdinjak
-
Nov 30, 2022, 11:55AM
Monday, November 07, 2022
Irwin Naturals THC Products To Be Available In Mississippi Cannabis Dispensaries
Vuk Zdinjak
-
Nov 7, 2022, 11:29AM
Thursday, November 03, 2022
Florida's Growing Psychedelic Treatment Options: Healthcare Company Expands Network Of Clinics
Lara Goldstein
-
Nov 3, 2022, 2:37PM
Tuesday, November 01, 2022
Ketamine Therapy: Revitalist's New Financing Option, Irwin Naturals Expands Chain Of Clinics
Lara Goldstein
-
Nov 1, 2022, 2:19PM
Friday, October 07, 2022
Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More
Lara Goldstein
-
Oct 7, 2022, 5:13PM
Wednesday, October 05, 2022
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
Lara Goldstein
-
Oct 5, 2022, 11:56AM
Tuesday, October 04, 2022
This Nutraceutical Company Stands To Become Leader In A Projected $50B Industry, New Analyst Insights
Jelena Martinovic
-
Oct 4, 2022, 3:46PM
Show more